Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: CBDW )

0.0094 UNCHANGED
Streaming Delayed Price Updated: 3:18 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0094
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0094
Today's Range 0.0094 - 0.0094
52wk Range 0.0078 - 0.2300
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1606 Corp. AI Chatbots Innovations, Highlights Adnexus LOI, and Quarterly Reporting Update After Q3 Filling
Via ACCESSWIRE
Adnexus Biotechnologies Inc. Appoints Dr. Hiroshi Ohrui to Scientific Advisory Board
Via ACCESSWIRE

Performance

YTD
-67.02%
-67.02%
1 Month
-28.24%
-28.24%
3 Month
-44.71%
-44.71%
6 Month
-71.52%
-71.52%
1 Year
-70.62%
-70.62%

More News

Read More
1606 Corp. Target for Strategic Investment Adnexus Biotechnologies Merges With Sanctum Therapeutics to Obtain Breakthrough HIV and SARS-CoV-2 Treatments
Via ACCESSWIRE
Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG
Via AB Newswire
Join 1606 Corp.'s Exclusive Live Investor Webinar and Q&A Session on October 10th
Via ACCESSWIRE
Adnexus Biotechnologies Unveils Sutra(TM), a Game-Changing AI Platform for Drug Discovery and Infectious Disease Research
Via ACCESSWIRE
Adnexus Biotechnologies Partners with 1606 Corp. for Strategic Investment to Revolutionize AI-Driven Drug Discovery
Via ACCESSWIRE
1606 Corp. (OTC: CBDW) Stock Surges on Game-Changing AI Acquisition LOI more stocks inside…
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
1606 Corp. Signs Letter of Intent to Acquire a Strategic Stake in Adnexus, a Leading AI Biotech Company
Via ACCESSWIRE
1606 Corp. Highlights New Leadership, AI Chatbots Innovations, and Quarterly Reporting Update After Q2 Filling
Via ACCESSWIRE
1606 Corp. Announces Austen Lambrecht as CEO and Chairman of the Board
Via ACCESSWIRE
1606 Corp. to Host Exclusive Live Investor Webinar and Q&A Session on June 11th
Via ACCESSWIRE
1606 Corp. Reports Great Success on IR Chat Sales Push and Shows Increased Revenue Last Quarter
Via ACCESSWIRE
1606 Corp. Recaps Massive Response to IR Chat From Planet Microcap Show
Via ACCESSWIRE
1606 Corp. Unveils New AI Vertical: IR Chat, a Bot for Public Companies and Investors
Via ACCESSWIRE
1606 Corp. to Host Exclusive Live Investor Webinar and Q&A Session on April 11, 2024
Via ACCESSWIRE
1606 Corp., a Leader in AI Chatbot Technology, Launches Email Capture Feature to Enhance Customer Engagement
Via ACCESSWIRE
1606 Corp. Announces AI ChatBot Product Development for Financial Industry
Via ACCESSWIRE
Navigating the Future: 1606 Corp’s (CBDW) Strategic Milestones and Vision for conversational AI Merchandising & E-Commerce
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
1606 Corp. Recaps Major Accomplishments in February & Provides Outlook For March
Via ACCESSWIRE
1606 Corp (CBDW) rises in AI-Driven Conversational E-Commerce
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
1606 Corp. (OTC:CBDW) Unveils AI-Powered ChatCBD Chatbot
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
1606 Corp. (CBDW) Unveils AI-Powered ChatCBD Chatbot
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
THC Mushroom Gummies To AI Cannabis Chatbots: Elevate Your Brand With Latest Innovations At This Conference
Via Benzinga
Topics Artificial Intelligence Cannabis
Exposures Artificial Intelligence Cannabis
Marijuana Stock Movers For August 22, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.